购物车
- 全部删除
- 您的购物车当前为空
GLPG3312 (化合物 28) 是一种选择性泛型SIK抑制剂,其对SIK1、SIK2和SIK3的IC50值分别为2.0 nM、0.7 nM和0.6 nM。GLPG3312在体外人类原代髓系细胞和体内小鼠模型中展示了抗炎和免疫调节活性,且具有良好的口服生物利用度,可用于炎症和免疫疾病的研究。
GLPG3312 (化合物 28) 是一种选择性泛型SIK抑制剂,其对SIK1、SIK2和SIK3的IC50值分别为2.0 nM、0.7 nM和0.6 nM。GLPG3312在体外人类原代髓系细胞和体内小鼠模型中展示了抗炎和免疫调节活性,且具有良好的口服生物利用度,可用于炎症和免疫疾病的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | GLPG3312 (Compound 28), characterized as a selective pan-SIK inhibitor, exhibits IC50 values of 2.0 nM for SIK1, 0.7 nM for SIK2, and 0.6 nM for SIK3. Demonstrating both anti-inflammatory and immunomodulatory activities, this compound effectively targets human primary myeloid cells in vitro and mouse models in vivo. With favorable oral bioavailability, GLPG3312 serves as a promising agent for the study of inflammatory and immune diseases [1]. |
靶点活性 | SIK3:0.6 nM, SIK2:0.7 nM, SIK1:2.0 nM |
分子量 | 453.44 |
分子式 | C23H21F2N5O3 |
CAS No. | 2340388-72-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容